Related Experiment Video
Updated: Oct 23, 2025

Implantation of Electroencephalogram and Electrocardiogram Telemetry Devices in Neonatal Rabbit Kits
Published on: February 28, 2025
Sudden cardiac death in a young boy with multisystemic inflammatory syndrome in children (MISC)
Gurudutta Avathi Venkatesha1, Nidhi Srinivas1, Saril Mohamedali2
1Paediatric Department, Rangadore Memorial Hospital, Bangalore, Karnataka, India.
Insights
Sudden cardiac death occurred in a child with multisystemic inflammatory syndrome in children (MISC) after initial recovery. This highlights the risk of fatal cardiac events during follow-up for MISC patients.
Area of Science:
- Pediatric Cardiology
- Infectious Diseases
- Critical Care Medicine
Background:
- Multisystemic inflammatory syndrome in children (MISC) temporally associated with SARS-CoV-2 is a serious condition.
- Cardiovascular complications are a known cause of mortality during the acute phase of MISC.
Observation:
- A previously healthy 12-year-old boy with MISC presented with cardiogenic shock and multiple organ dysfunction syndrome.
- After initial improvement with intravenous immunoglobulin and steroids, the child experienced sudden cardiac arrest and died.
- No reversible cause was identified during resuscitation efforts.
Findings:
- Despite apparent recovery of myocardial function, cytokine-induced inflammation may render the myocardium arrhythmogenic.
- This case represents the first reported instance of sudden cardiac death in a child with MISC days after critical illness recovery.
- The risk of fatal outcomes persists during follow-up, even without coronary aneurysms.
Implications:
- This case underscores the potential for delayed fatal cardiovascular events in children with MISC.
- Further research is needed to identify clinical predictors of high-risk children with MISC.
- Close monitoring and long-term follow-up are crucial for understanding and managing MISC sequelae.
Abstract:
A previously healthy 12-year-old boy presented to the emergency department on the seventh day of illness with classical symptoms of postinflammatory multisystemic syndrome in children temporally associated with SARS-CoV-2 (fever, vomiting, loose stools and rashes all over the body) with COVID-19 seropositivity, high inflammatory markers and elevated cardiac enzymes with cardiogenic shock with multiple organ dysfunction syndrome. After having improved over the first 48 hours following intravenous immunoglobulin and pulsed steroids, this young boy developed sudden cardiac arrest and died. No reversible cause could be identified at the time of resuscitation. Despite an apparent clinical recovery in the myocardial function, it is likely that the myocardium remains arrhythmogenic due to cytokine-induced myocardial inflammation. There are several reports in the literature of fatality in multisystemic inflammatory syndrome in children (MISC) due to cardiovascular complication during the acute phase of the illness. To the best of our knowledge, this is the first report of sudden cardiac death in a child with MISC days after recovery from critical illness, suggesting that fatal outcome remains a potential risk during follow-up, even when there is no evidence of coronary aneurysm. Further studies are needed to identify clinical characteristics of such high-risk children presenting with MISC. We will need to follow these children closely to understand what implications they may have in the long term, and this helps in raising awareness among families of such children.
More Related Videos
07:50A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
Published on: September 20, 2018
09:16Isolation and Characterization of Cardiac Mesenchymal Stromal Cells from Endomyocardial Bioptic Samples of Arrhythmogenic Cardiomyopathy Patients
Published on: February 28, 2018
Related Concept Videos
Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis I: Introduction
Cardiomyopathy I: Introduction and Classification
Acute Coronary Syndrome I: Introduction
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Myocarditis III: Medical Management